Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Hypothyroidism and ABCG2[original query] |
---|
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. Acta clinica Belgica 2018 May 1-9. Werbrouck Emilie, Bastin Julie, Lambrechts Diether, Verbiest Annelies, Van Brussel Thomas, Lerut Evelyne, Machiels Jean-Pascal, Verschaeve Vincent, Richard Vincent, Debruyne Philip R, Decallonne Brigitte, Schöffski Patrick, Bechter Oliver, Wolter Pascal, Beuselinck Beno |
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: